Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study

OBJECTIVES: To quantify within-subject change in symptom, laryngoscopic and quality-of-life measures after 8 weeks of adjunctive nebulised N-acetylcysteine (NAC) in adults with laryngopharyngeal symptoms (LPS) persisting despite proton-pump-inhibitor (PPI) therapy, and to explore baseline predictors of response. DESIGN: Prospective, single-arm, pre-post interventional study. SETTING: Tertiary otolaryngology practice. PARTICIPANTS: Seventy-five adults with LPS persisting after ≥ 12 weeks of PPI therapy (baseline Reflux Symptom Index [RSI] ≥ 13 and Reflux Finding Score [RFS] ≥ 7); ambulatory reflux monitoring was not performed. MAIN OUTCOME MEASURES: Change in RSI (primary). Secondary: RFS, the 12-item Reflux Symptom Score (RSS-12) and the laryngopharyngeal reflux health-related quality-of-life instrument (LPR-HRQoL). Treatment response (≥ 50% RSI reduction or end-of-treatment RSI < 13) was modelled by logistic regression. RESULTS: All outcomes improved at Week 8: RSI -10.2 points (95% CI -11.2 to -9.2; Cohen's d_z = -2.33), RFS -6.1 (d_z = -1.88), RSS-12 - 33.9 (d_z = -1.30) and LPR-HRQoL +20.0 (d_z = +2.17) (all p < 0.001). Thirty-nine of 75 (52.0%) were responders. A twice-daily PPI regimen was independently associated with response (adjusted odds ratio [OR] 4.96, 95% CI 1.41-17.43; p = 0.012) and higher baseline RSI with non-response (adjusted OR 0.70 per point, 95% CI 0.56-0.87; p = 0.002). CONCLUSIONS: Nebulised NAC with saline was associated with large improvements across symptom, laryngoscopic and quality-of-life domains in adults with LPS persisting despite PPI therapy and was well tolerated. As the study was uncontrolled and the saline vehicle may itself relieve symptoms, efficacy requires confirmation in a randomised trial against nebulised saline.

Authors

Institutions

Publication Details

Journal
Clinical Otolaryngology
Published
2026-11-13
DOI
https://doi.org/10.1111/coa.70195
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study

Han Wool John Sung, Bon Seok Koo, Sumin Yi, Jae Won Chang et al.
Clinical Otolaryngology
Gastroesophageal reflux and treatments
article

Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study

Han Wool John Sung, Bon Seok Koo, Sumin Yi, Jae Won Chang, Sang Heun Kim, Hyo One Son
article en

Abstract

OBJECTIVES: To quantify within-subject change in symptom, laryngoscopic and quality-of-life measures after 8 weeks of adjunctive nebulised N-acetylcysteine (NAC) in adults with laryngopharyngeal symptoms (LPS) persisting despite proton-pump-inhibitor (PPI) therapy, and to explore baseline predictors of response. DESIGN: Prospective, single-arm, pre-post interventional study. SETTING: Tertiary otolaryngology practice. PARTICIPANTS: Seventy-five adults with LPS persisting after ≥ 12 weeks of PPI therapy (baseline Reflux Symptom Index [RSI] ≥ 13 and Reflux Finding Score [RFS] ≥ 7); ambulatory reflux monitoring was not performed. MAIN OUTCOME MEASURES: Change in RSI (primary). Secondary: RFS, the 12-item Reflux Symptom Score (RSS-12) and the laryngopharyngeal reflux health-related quality-of-life instrument (LPR-HRQoL). Treatment response (≥ 50% RSI reduction or end-of-treatment RSI < 13) was modelled by logistic regression. RESULTS: All outcomes improved at Week 8: RSI -10.2 points (95% CI -11.2 to -9.2; Cohen's d_z = -2.33), RFS -6.1 (d_z = -1.88), RSS-12 - 33.9 (d_z = -1.30) and LPR-HRQoL +20.0 (d_z = +2.17) (all p < 0.001). Thirty-nine of 75 (52.0%) were responders. A twice-daily PPI regimen was independently associated with response (adjusted odds ratio [OR] 4.96, 95% CI 1.41-17.43; p = 0.012) and higher baseline RSI with non-response (adjusted OR 0.70 per point, 95% CI 0.56-0.87; p = 0.002). CONCLUSIONS: Nebulised NAC with saline was associated with large improvements across symptom, laryngoscopic and quality-of-life domains in adults with LPS persisting despite PPI therapy and was well tolerated. As the study was uncontrolled and the saline vehicle may itself relieve symptoms, efficacy requires confirmation in a randomised trial against nebulised saline.

Clinical Otolaryngology
Chungnam National University (KR), Chungnam National University Hospital (KR)
Chungnam National University
Good health and well-being
Gastroesophageal reflux and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon